Literature DB >> 8988884

Induced abortion and the risk of breast cancer.

M Melbye1, J Wohlfahrt, J H Olsen, M Frisch, T Westergaard, K Helweg-Larsen, P K Andersen.   

Abstract

BACKGROUND: It has been hypothesized that an interrupted pregnancy might increase a woman's risk of breast cancer because breast cells could proliferate without the later protective effect of differentiation.
METHODS: We established a population-based cohort with information on parity and vital status consisting of all Danish women born from April 1, 1935, through March 31, 1978. Through linkage with the National Registry of Induced Abortions, information on the number and dates of induced abortions among those women was combined with information on the gestational age of each aborted fetus. All new cases of breast cancer were identified through linkage with the Danish Cancer Registry.
RESULTS: In the cohort of 1.5 million women (28.5 million person-years), we identified 370,715 induced abortions among 280,965 women (2.7 million person-years) and 10,246 women with breast cancer. After adjustment for known risk factors, induced abortion was not associated with an increased risk of breast cancer (relative risk, 1.00; 95 percent confidence interval, 0.94 to 1.06). No increases in risk were found in subgroups defined according to age at abortion, parity, time since abortion, or age at diagnosis of breast cancer. The relative risk of breast cancer increased with increasing gestational age of the fetus at the time of the most recent induced abortion: <7 weeks, 0.81 (95 percent confidence interval, 0.58 to 1.13); 7 to 8 weeks, 1.01 (0.89 to 1.14); 9 to 10 weeks, 1.00 >12 weeks, 1.38 (1.00 to 1.90) (reference category, 9 to 10 weeks).
CONCLUSIONS: Induced abortions have no overall effect on the risk of breast cancer.

Entities:  

Keywords:  Abortion, Induced; Biology; Breast Cancer--determinants; Cancer; Denmark; Developed Countries; Diseases; Europe; Family Planning; Fertility Control, Postconception; Neoplasms; Northern Europe; Research Report; Risk Factors; Scandinavia

Mesh:

Year:  1997        PMID: 8988884     DOI: 10.1056/NEJM199701093360201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  28 in total

1.  Abortion and breast cancer: a case-control record linkage study.

Authors:  M J Goldacre; L M Kurina; V Seagroatt; D Yeates
Journal:  J Epidemiol Community Health       Date:  2001-05       Impact factor: 3.710

2.  Selling sickness: the pharmaceutical industry and disease mongering.

Authors:  Ray Moynihan; Iona Heath; David Henry
Journal:  BMJ       Date:  2002-04-13

Review 3.  Early breast cancer.

Authors:  Tomoyoshi Suzuki; Masakazu Toi; Shigehira Saji; Kazumi Horiguchi; Tomoyuki Aruga; Eiji Suzuki; Shinichiro Horiguchi; Nobuaki Funata; Katsuyuki Karasawa; Noriko Kamata
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

4.  Interactions between genetic and reproductive factors in breast cancer risk in a French family sample.

Authors:  N Andrieu; F Demenais
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  Politics, power, and procreation.

Authors:  David A Grimes
Journal:  MedGenMed       Date:  2005-06-15

6.  Induced abortion as an independent risk factor for breast cancer.

Authors:  M Blettner; J Chang-Claude; T Scheuchenpflug
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

7.  When the entire population is the sample: strengths and limitations in register-based epidemiology.

Authors:  Lau Caspar Thygesen; Annette Kjær Ersbøll
Journal:  Eur J Epidemiol       Date:  2014-01-10       Impact factor: 8.082

8.  Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies.

Authors:  Yu-Long Lan; Xun Wang; Jia-Cheng Lou; Bin-Bin Ma; Jin-Shan Xing; Shuang Zou; Bo Zhang
Journal:  J Neurooncol       Date:  2017-12-26       Impact factor: 4.130

9.  A case-control study of oral contraceptive use and incident breast cancer.

Authors:  Lynn Rosenberg; Yuqing Zhang; Patricia F Coogan; Brian L Strom; Julie R Palmer
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

10.  Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study.

Authors:  Rune Gärtner; Deirdre Cronin-Fenton; Heidi H Hundborg; Lars Pedersen; Timothy L Lash; Henrik Toft Sørensen; Niels Kroman
Journal:  BMC Surg       Date:  2010-01-24       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.